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Abstract 
Introduction: Stroke is a prevalent acute illness in our society that can cause life-long 
debilitating deficits and in some cases can be fatal. The administration of recumbent tissue 
plasminogen activator, also known as Alteplase, is associated with better long-term outcomes, 
lower mortality rates, and decreased deficits when given rapidly following diagnosis. We aim to 
decrease the time from patient arrival to Alteplase administration in a small, rural emergency 
department in Pennsylvania by identifying delays and creating a workflow allowing for seamless 
identification and treatment of acute ischemic stroke. Methods: Areas of delays were identified 
following in-unit observation and an extensive literature search. An improved workflow was 
created and implemented along with a standing order set allowing the patient to obtain CT scan 
prior to being placed in a room. Findings: On a single patient walk through of the revised 
workflow the door to stroke alert time, door to CT scan time, and door to Patronus Neurology 
tele-consult times were all decreased from the previous quarter’s average. Discussion: Through 
implementation of a nurse-driven stroke alert protocol the triage nurse was empowered to 
identify a stroke, call a level one stroke alert, and facilitate the CT scan process all independent 
of physician guidance. Implications: By reducing these time spans and receiving Alteplase 
administration in a timely fashion, patients will appreciate better long-term outcomes and fewer 
deficits. 
Key Words: stroke, alteplase, tPA, ischemic, thrombolytic, door-to-needle, DNT, CT scan, 
workflow, standing order set   
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CHAPTER 1. 
Workflow of Stroke Patients Arriving by Personal Vehicle 
Every 40 seconds someone in the United States sustains a stroke, and every four minutes 
an individual dies from this stroke (Rhew et al., 2017). With statistics as staggering as these, 
stroke effects each of us in one way or another, whether it be ourselves or a loved one that 
succumbs to a stroke. There are national efforts to increase education about stroke symptoms, 
prevention, and treatment with an emphasis on how crucial of a factor time is. For each minute 
that a large-vessel occlusion, or ischemic stroke, goes untreated 1.9 billion neurons and 13.8 
billion synapses are lost which in one hour is equivalent to the same loss that would occur in 3.6 
years of the natural aging process (Speirs & Mitchell, 2015). The door-to-needle time (DNT) is 
the time that lapses between the time a patient arrives in the emergency department (ED) and the 
time that intravenous recombinant tissue plasminogen activator (tPA), otherwise known as the 
pharmaceutical drug Alteplase is administered. It is this metric that I hope to reduce in a small 
rural ED in Pennsylvania utilizing the framework of Kurt Lewin’s change theory through the 
implementation of an improved workflow for patients arriving via personal vehicle with an acute 
ischemic stroke. 
Clinical Practice Problem 
A patient suffering from stroke or stroke-like symptoms who summons emergency 
medical services (EMS) gives themselves a slight advantage over those individuals who choose 
to be driven to the hospital via personal vehicle because the hospital staff is aware of their 
condition and estimated time of arrival and can be prepared to meet them at the door. At the 
community hospital studied in the microsystem assessment, the average time from door to 
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Alteplase administration over the past year was 54 minutes when arriving by private vehicle 
compared to 45 minutes when arriving via Emergency Medical Services (EMS) (Evangelical 
Community Hospital, 2020). While this is within the national standard of 60 minutes, the 
literature shows that there is a direct relational benefit to more rapid administration of Alteplase 
to within 30 minutes of arrival to achieve the best possible outcomes (Yang et al., 2014; Elder et 
al., 2015; Yoo et al., 2018; Min-Yi et al., 2019; Tran et al., 2019).  
PICOT Statement 
In patients with acute ischemic stroke symptoms arriving via personal vehicle to the 
emergency department, does the use of an improved stroke workflow and a standardized order 
set as opposed to the use of the current stroke workflow and no order set decrease the average 
time from door to Alteplase administration as measured in minutes? 
Global Aim Statement 
We aim to improve the average time from door to Alteplase administration in patients 
arriving with acute ischemic stroke symptoms via personal vehicle to the emergency department. 
The process begins with reconfiguring the workflow to allow the stroke alert to be activated 
within the triage bay allowing the patient to receive a CT scan prior to being placed in a room. 
The process ends with timely interpretation of radiologic scans and subsequent prompt 
administration of Alteplase to applicable patients. By working on the process, we expect 
decreased times from door to CT scan, decreased times from door to Alteplase administration, 
and thus higher incidents of patients surviving strokes with decreased lasting deficits. It is 
important to work on this now because the current process takes an average of 54 minutes and 
the emergency department has elected lowering this number as their 2020-2021 quality initiative. 
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Patient Population 
Approximately 88% of all admitted patients enter this hospital through the emergency 
department as opposed to other routes such as direct admissions or transfers from other facilities 
according to the microsystem assessment completed. Of these patients, the majority (37.1%) 
were aged 76 years or older with the next closest (25.9%) aged 66 to 75 years, meaning the 
patient population is primarily composed of the elderly. The gender comparison was close, 
yielding 54% males to 46% females, and information regarding patients’ living situation prior to 
presentation was unavailable. The most prevalent admitting diagnosis was sepsis with an 
unspecified source; cerebral infarction was not found until the seventh leading diagnosis on this 
list. The majority of patients (60%) are discharged to home while 18% are discharged to a skilled 
nursing facility and the remaining 22% are discharged to other locations. 
Practice Environment 
The emergency department at this small rural hospital contains 18 beds and 4 triage suites 
contained in an area known to staff as the pit. Currently, construction is underway in and around 
the ED to expand the hospital as a whole and provide more private rooms for admitted patients. 
This construction has been ongoing for over a year, and adds an extra level of stress and 
disorganization to staff that is worth mentioning and keeping in mind as we implement this 
project. The layout of the ED is thoughtfully done with the radiology department directly outside 
the doors to the unit which allows for easy access and transport of critical patients, namely those 
suspected of having a stroke. The unit as a whole is fast paced yet well organized and all staff 
seem to not only know their own roles but also how and when to assist colleagues to provide the 
best total care for the patients.  
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Strengths 
Identified strengths within the emergency department which pertain directly to the 
workflow improvement implementation project are as follows: 
1) Support from higher management 
2) Pre-existence of a stroke alert protocol 
3) Visibility of student within the unit and open communication about the project 
The strengths leading into this project far outweigh the weaknesses. The support from 
management has been present from the initial project suggestion and with current stroke alert 
protocols already in place we are essentially taking a current process and offering opportunities 
to build and enhance upon it. I have been visible around the unit, have introduced myself to the 
majority of the staff I have worked alongside, and have been speaking to them about the 
upcoming project to not only get a feel for where they are desiring change, but to build 
excitement around the unit of the prospective improvements to come.  
Weaknesses 
Likewise, areas of weakness were identified within the emergency department which may 
serve as hinderances to successfully implementing this project. They are as follows: 
1) Aversion to change shown by seasoned staff 
2) Staff noncompliance with assigned tasks 
3) Concurrent unit construction 
The most difficult hurdle to overcome with this project implementation will be gaining 
staff’s approval and desire to change, especially within the senior staff population. Those who 
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have been working on a unit for a length of time do not readily want a student coming in to 
change things without giving some push-back, and I anticipate that to be the case in a handful of 
individuals. Along the same line, staff have been historically noncompliant with things such as 
checking or responding to e-mails, completing surveys, or adhering to new documentation within 
the electronic health record. A simple incentive, such as a small food item or gift card raffle will 
need to be applied in order to gain staff participation in some areas, namely getting feedback and 
maintaining compliance with the change. Finally, as previously stated, the unit is currently 
surrounded by construction equipment and workers, which adds a slight feeling of 
disorganization that may cause staff to be less receptive to further change. 
Interdisciplinary Communication 
The layout of the emergency department allows for easy and open communication 
between nursing, physicians, nursing assistants, and all members of the patient care team. While 
interdisciplinary rounds are not completed as they are on inpatient units, all members of the 
patient care team are in constant communication about the patient’s diagnosis, vital sign trends, 
and goals. They work together to develop a plan of care that is patient-specific, and they ensure 
that all members of the team are informed of the plan and their individual roles within it. The 
electronic health record helps to close the communication loop by compiling data entered by 
each of the various disciplines and making it readily viewable to all members of the care team. 
From the time I have spent thus far observing in the ED, there doesn’t appear to be any issues 
with patronizing or looking down on another’s role in the patient’s care. Staff speak to one 
another as respected peers which is important to achieve the best possible patient outcomes. 
Collaboration 
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The emergency room must collaborate externally with local EMS, local skilled nursing 
facilities, area police departments and internally with the radiology department, patient transport, 
and the inpatient units. These collaborations allow for seamless patient flow and avoid causing a 
back-up of patients waiting to depart to their next location. On the intake side, these three 
external agents transmit communications to the ED, alerting them of incoming patients, acuity, 
and estimated time of arrival. This notification allows ED staff to make available a room and any 
necessary staff or equipment needed to greet the patient. On the internal end of things, 
communication with the radiology department is critical for implementation of this project to 
allow suspected stroke patients faster door-to-CT scan times. Collaborating with patient transport 
and the inpatient units is crucial in such a small ED to optimize the turnover of rooms. 
Chapter 2. LITERATURE REVIEW 
Initial Literature Search 
An extensive literature review was performed on the topic of acute ischemic stroke and 
alteplase administration. The Nursing & Allied Health Database was first utilized with a search 
of the key words ‘stroke’ and ‘alteplase’ - this yielded 2,698 results. The search limitations of 
‘full text’ and ‘peer reviewed’ were applied as well as the date range limitation of 2014-present 
and only articles in the English language were filtered out which yielded 694 results. Repeat 
searches of the same database and with the same limitations were conducted with the following 
key words and result yields; ‘door-to-needle reduction’ 120 results, ‘stroke’ and ‘standing order’ 
18 results, ‘stroke work flow’ and ‘alteplase’ 189 results and ‘alteplase delay’ 336 results.  
The same five searches were then conducted using the Medline with Full Text database 
utilizing the same limitations as well as ‘age - all adults 19+ years.’ The initial search of ‘stroke’ 
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and alteplase’ yielded 224 results, subsequent findings were ‘door-to-needle reduction’ yielding 
zero results but 1,172 results based on key words, ‘stoke’ and ‘standing order’ yielding zero 
results and zero related search results, ‘stroke work flow’ and ‘alteplase’ yielding zero exact 
results but 70 results based on keywords, and ‘alteplase delay’ yielding zero exact results but 3 
results based on keywords. 
Given the surplus of articles gathered from these searches, the titles of each were 
reviewed for relevance to this improvement project and articles which contained an abstract were 
scoured with relevant data highlighted for further review. Once these were narrowed down to 25 
articles, each were read thoroughly and 15 which were directly pertinent to this project were 
selected for inclusion. These final 15 were read through a second time with relevant data being 
gathered and compiled in an evidence matrix, see Appendix A.  
Stroke Statistics 
I would briefly like to review the statistics on stroke presented in the literature, as there 
are some discrepancies among the articles. Stroke is identified as the third leading cause of death 
by Rhew et al. (2017), however Elder et al. (2015) and Speirs & Mitchell (2015) identify stroke 
as the fourth leading cause of death in the United States. The implication of this inconsistency is 
that through the years, stroke prevalence has increased such that is has moved up from the fourth 
leading cause in 2015 to the third leading cause in 2017, meaning that there must be a focus 
today on more education about stroke and prevention measures.  
Not surprisingly, the definition and/or cause of an acute ischemic stroke is evaluated in 
three studies (Elder et al., 2015; Zerna et al., 2018; Tran et al., 2019) and additional statistical 
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facts are presented in two articles (Speirs & Mitchell, 2015; Rhew et al., 2017). Please see the 
full evidence matrix, Appendix A, for further details. 
Treatment of Acute Ischemic Stroke 
Recombinant tissue plasminogen activator (tPA), otherwise known as the Food and Drug 
Administration (FDA) approved pharmacological intervention, Alteplase, was unanimously 
stated to be the primary standard treatment for acute ischemic stroke (Emberson et al., 2014; 
Yang et al., 2014; Elder et al., 2015; Speirs & Mitchell, 2015; Yoo et al., 2018; Zerna et al., 
2018; Campbell et al., 2019; Tennyson et al., 2019; Tran et al., 2019; Jaffe et al., 2020; Kamal et 
al., 2020 Man et al., 2020). Zerna et al. (2018) and Min-Yi et al. (2019) go on to discuss the 
benefits of advancing to endovascular thrombectomy (EVT) for large vessel occlusion strokes in 
patients who are not Alteplase candidates. While EVT is a vital component of stroke treatment, it 
is not directly pertinent to the goal of this workflow improvement process, therefore, further 
information on this topic will not be discussed but can be viewed within the evidence matrix, 
Appendix A.   
Exact timeframes in which Alteplase could or should be administered varied among the 
literature. Five articles claimed no specific time parameters, but noted that Alteplase should be 
given as rapidly as possible following initial symptom onset to achieve the best outcomes (Yang 
et al., 2014; Elder et al., 2015; Yoo et al., 2018; Min-Yi et al., 2019; Tran et al., 2019). Some 
articles note target DNTs as recommended by various organizations/initiatives such as the 
American Heart Association’s goal of administration within 60 minutes (Speirs & Mitchell, 
2015; Jaffe et al., 2020; Man et al., 2020), the US Target: Stroke Initiative’s goal of 
administration within 45 minutes (Kamal et al., 2020) and an unnamed “framework for acute 
ischemic stroke therapeutics” target of 30 minutes or less (Zerna et al., 2018, p. 1254). Two 
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studies have corroborated the benefits of administering Alteplase within 4.5 hours of symptom 
onset or LKWT (Emberson et al., 2014; Tennyson et al., 2019) while Campbell et al. (2019) 
boasts that administration up to nine hours from stroke symptom onset or in those with wake-up 
stroke symptoms with salvageable brain tissue shown on imaging has shown improved 
functional outcomes. Emberson et al. (2014) and Zerna et al. (2018) discuss that Alteplase has 
only been approved or licensed by the FDA for administration within three hours of stroke 
symptom onset.  
The time at which Alteplase reaches a neutral effect or has an inverse risks/benefits ratio 
has been controversial in this literature. Zerna et al. (2018) states that they have found no average 
benefit of Alteplase administration after 270 minutes, or 4.5 hours, from stoke symptom onset 
and feel that to be the time as which the medication approaches a neutral effect, as where 
Emberson et al. (2014) estimated the time at which Alteplase has no effect to be 6.3 hours. 
Although the general consensus is that faster administration of Alteplase is directly correlated to 
increased outcomes, Man et al. (2020) revealed that DTN within 30 minutes was not associated 
with even better outcomes than those who received it within 45 minutes. Interestingly, Emberson 
et al. (2014) found that neither age nor stroke severity modified the therapeutic effect of 
Alteplase. 
Delving deeper into Alteplase administration, the research has shown that patients have 
been found to have better long-term functional outcomes as measured at three and six months by 
the Oxford Handicap Scale Outcome Assessment (Emberson et al., 2014) and by the Modified 
Rankin Scale (mRS) at three months, one year, and 1.5 years (Man et al., 2020). Two studies 
reviewed outcomes as altered by a 15-minute difference in DTN; Speirs & Mitchell (2015) 
studied found that for every 15-minute DTN reduction, the mortality rate decreased by 5% and 
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similarly yet reversely studied, Man et al. (2020) showed that for every 15-minute increase in 
DTN there was a direct correlation with higher all-cause mortality and all-cause readmission. An 
interesting postulation by Zerna et al. (2018) related to outcomes measurement is that the NIHSS 
score does not weigh deficits or disability equally and is therefore not an accurate depiction of 
stroke severity or stroke impact on quality of life. 
 Risk versus benefit of Alteplase administration was not as heavily discussed throughout 
the literature as one would assume given that it carries severe and potentially life-threatening 
side effects such as bleeding and subsequent intra-cranial hemorrhage (Genentech USA, 2020). 
Campbell et al. revealed that “the number of patients with symptomatic intracerebral hemorrhage 
was significantly higher in the alteplase group than the placebo group [...] however, no 
significant differences were identified in mortality” (2019, p. 143). Emberson et al. (2014) found 
that the proportional increase in risk of fatal intracranial hemorrhage was the same regardless of 
treatment delay time, patient age, or stroke severity. I believe the literature is lacking a 
discussion about this potentially fatal outcome and more research should be done in this area. 
Delays in Treatment 
Zerna et al. (2018) identified that approximately 25% of all ischemic strokes are eligible 
for thrombolysis, however Rhew et al. (2017) states that fewer than 5% of patients who are 
eligible for acute treatment actually receive intravenous thrombolytic drugs. The literature 
presented an extensive list of reasons treatment may be delayed, and it can be broken down into 
three sub-categories. 
Timing. The causes of Alteplase administration delay highlighted by these articles are 
factors that must be considered and planned for, but in most cases cannot be avoided. Rhew et al. 
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(2017) starts this discussion by stating that at least 50% of the United States population lives 
further than 60 minutes travel time from a primary stroke center which is further complicated by 
the finding of Speirs & Mitchell that “most time is lost in the prehospital setting primarily 
because patients delay seeking medical attention” (2015, p. 382). Two studies looked at patients 
who arrive on ‘off-hours,’ noted to be nights, weekends, and holidays, but had polar opposite 
results. Man et al. (2020) found that patients arriving with ischemic stroke during these off-hours 
did not experience longer DNT than patients arriving during weekday daylight hours as where 
Yang et al. (2014) acknowledged studies claiming this but found themselves that patients 
arriving during off-hours had longer DNT and were associated with poorer outcomes and 
mortality rates. Yang et al. did go on to hypothesize that these results may be reflective of 
common off-hour handicaps such as “discontinuity of care, inadequate staffing, reduced 
availability of interventions, and an overall reduction in supervision of patients” (2014, p. 887). 
Jaffe et al. (2020) looked at the impact of emergency department crowding on DNT and found 
that there were no significant delays associated with increased crowding. Jaffe further postulated 
that these findings may be due to increased resource availability during times of peak crowding, 
which were found to be from “Monday through Thursday the median [‘severe crowding’] 
activation time of 1:35pm” (2020, p. 894). 
Triage. The majority of identified delays in Alteplase administration throughout the 
literature were found within the triage process. Triage staff have been found to either 
misdiagnose a stroke, or miss a stroke altogether when patients presents with poor baseline 
function (Min-Yi et al., 2019), mild stroke with isolated symptoms or minor neurologic deficits 
(Yoo et al., 2018), or stroke mimics such as seizures, syncope, sepsis, conversion disorder, 
migraine, brain tumor, or hypoglycemia (Catangui, 2019). Yoo et al. (2018) goes on to discuss 
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how the initial non-diagnosis or misdiagnosis of stroke can delay all subsequent interventions, 
ultimately effecting DNT and outcomes.  
One surprising finding was emergency department (ED) staff reliance on EMS personnel 
to identify strokes and give pre-notification prior to arrival creating a false sense of security. 
While the workflow improvement project focuses on patients arriving via personal vehicle, I feel 
it is necessary to recognize this bias as it creates unequal assessment performance based on the 
patient’s mode of arrival. Tennyson et al. was that “stoke patients arriving via the ‘front door’ 
enjoyed more timely recognition and resource activation by ED staff than those arriving via the 
ambulance entrance if EMS had not already recognized the stroke symptoms in the field” (2019, 
p. 346) which was further corroborated by Speirs & Mitchell who cited “no pre-notification of 
the impending arrival of a stroke patient” (2015, p. 381) as an identified delay in treatment.  
Hospital processes. The remainder of the identified delays in Alteplase administration 
involve the current procedures, implementations, or lack-there-of within the emergency 
department and included uncontrolled hypertension on arrival associated with a more than 30 
minute delay to pharmacologically manage (Tran et al., 2019), location of the computed 
tomography (CT) scanner, lack of dedicated stroke team, lack of standardized stroke treatment 
protocols, inefficient patient flow, and the serial processing of multiple tasks (Speirs & Mitchell, 
2015). One delay noted in both articles was the time taken for laboratory and imaging tests to 
result associated with a delay of up to 60 minutes (Speirs & Mitchell, 2015; Tran et al., 2019).  
Proven Time Reduction Techniques 
The summation of literature yielded a list of improvement opportunities which are 
directly transferrable to this specific workflow improvement project as well as to any emergency 
STROKE WORKFLOW ARRIVING BY PERSONAL VEHICLE  17 
 
   
 
department wishing to reduce their DNT. Operational interventions shown to be effective in 
reducing DNT and/or improving outcome include the implementation of a clinical pathway or 
systematic alert system (Yang et al., 2014), creating and training stroke teams, implementing 
preapproved standardized treatment protocols, postponing nonessential components of care until 
after completion of the CT scan, creation of a readily available ‘stroke box’ stocked with all 
necessary supplies for tPA administration (Speirs & Mitchell, 2015), utilizing a standard order 
set or written care protocols within an electronic medical record (EMR) (Elder et al., 2015), and 
providing educational programs for ED triage staff to ease early and accurate detection of stroke 
(Yoo et al., 2018). Speirs & Mitchell (2015) go on to discuss the importance of gaining 
administrative support with these implementations and the benefits of continually monitoring 
and evaluating performance of staff post-implementation.  
The literature regarding the creation of a standard order set was of key importance, as this 
plans to be a primary element of my workflow improvement project. Elder et al. considers the 
importance of a standing order set as part of a multidisciplinary approach to stroke treatment 
when integrated within the EMR at primary stroke centers and cites that “a patient treated 
without the order set was 2.4 times more likely to receive care that was not in compliance with 
all mandatory standards” (2015, p. S8). This study further found that of the physicians who 
utilized the order set, 94% were neurologists, and that many of the physicians made 
modifications to the order set, thus defeating the purpose of standardization (Elder et al., 2015). 
Chapter 3. PROJECT PLAN 
Project Aim, Objectives, and Desired Outcomes 
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The overall aim of my capstone project is to decrease the time from door to Alteplase 
(tPA) administration in applicable patients arriving to the emergency department via personal 
vehicle in a community hospital. There are a number of contributing factors that can delay the 
administration of this potentially life-saving medication, and they are portrayed in the following 
fishbone diagram, Figure 1. Starting with the patient’s themselves, the method of transportation 
to the hospital can remove precious time. Some patients exhibit denial that they are having a 
stroke and may try to ignore symptoms or self-medicate with over-the-counter medications for 
various symptoms. One would hope that a patient experiencing stroke symptoms would have a 
family member or loved one drive them to the hospital, or more preferably call EMS, but 
sometimes these extraneous bystanders can actually hinder care by trying to overstep medical 
professionals, interject into assessment questions, or giving incorrect details about the patient’s 
last known well time (LKWT).  
Once the patient reaches the hospital, they are seen by triage in the order of which they 
arrive, unless someone is obviously bleeding or in acute distress which is not always the case in 
stroke patients with minimal or early symptoms. Stemming from that same thought, the triage 
nurse is always prone to missing stroke symptoms since only a small portion of the patient’s 
story is told and some patients have slight or atypical symptoms. The flawed process is where I 
aim to implement change in that the patient is typically put into a room where other menial tasks 
are completed, the physician is off seeing other patients and time is lost. Once the physician does 
see the patient a number of factors must still take place before the patient can receive their CT 
scan; an assessment must take place and stroke alert called, an order for the scan must be written, 
the patient must have an intravenous line, no contrast allergies, and good renal function, and the 
radiology department must be prepared to take the patient. Given this extensive list of factors, we 
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aim to improve the order of the process to help eliminate domino-effect delays in Alteplase 
administration.  
 
Figure 1. Fishbone Diagram 
Plan, Do, Study, Act (PDSA Cycle) 
As discussed in various pretenses, the less time that lapses from when the patient arrives 
to the time, they receive Alteplase has been directly linked with better overall outcomes and 
decreased long-term residual deficits. The national average as dictated by the American Heart 
Association is that the stroke patient receives Alteplase administration within 60 minutes of 
being through the emergency room door (American Heart Association, 2020). Unfortunately, 
less than 30 percent of patients nation-wide are treated with Alteplase within this window 
(American Heart Association). One study researched the correlation between door to Alteplase 
time and 1-year-all-cause mortality and readmission; this same study found that “every fifteen-
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minute increase in door-to-needle time was associated with higher 1-year all-cause readmission 
and higher 1-year all-cause mortality” (Man et al., 2020, p. 2181). It is for this reason that we 
aim to re-design the current workflow of triaging stroke patients in the emergency department.  
As shown in the plan, do, study, act cycle diagram, Figure 2, this begins with observing 
the current process and creating a new workflow for approval by the stroke committee and 
emergency department management. Once this is approved, education can be dispersed, and the 
implementation can be brought about. After a short period of implementation, the new workflow 
should be observed again and feedback from staff as well as metrics should be collected and 
assessed. Finally, utilizing this data and staff feedback, the workflow should be modified as 
needed, if applicable, and new education provided throughout.   
 
Figure 2. Project Planning Model Based on PDSA Cycle 
Plan 
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The projection as shown in the run chart, Figure 3, is that the current door to Alteplase 
time frame, while currently acceptable, continues to trend shorter to ensure the best possible 
patient outcomes to a goal of 45 minutes or under by 2021. This will be achieved by taking the 
current stroke workflow and altering it so that the patient is taken directly from triage to the CT 
scanner before being placed in a room where other nonessential tasks may be completed and take 
up unnecessary time. A standard order set will be put in place to allow triage personnel to 
identify a stroke, activate the stroke alert, and get the patient to the CT scan all before the 
physician comes to assess the patient.  
 
Figure 3. Run Chart 
Do 
The following action plan outlines the timeline for this project from development through 
completion. 
1) Week of 6 September 2020: Observe current triage process for patients arriving via personal 
vehicle with stroke symptoms.  
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2) Week of 20 September 2020: Observe the current process for levels one, two, and three stroke 
alerts from door to Alteplase administration. 
3) Week of 4 October 2020: Create new workflow and associated chart for staff to review. 
4) Week of 18 October 2020: Present to emergency room staff, management, and educators for 
feedback and adjust as necessary. 
5) Week of 1 November 2020: Once finalized, present to higher management, policy board, and 
physician staff for approval. 
6) Week of 15 November 2020: Once approved create written and verbal education for staff and 
schedule sessions to provide training. 
7) Week of 29 November 2020: Implement, re-educate where necessary and begin measuring 
outcomes. 
In terms of additional resources required, the staff is already in place and this 
improvement project should not require any additional financial support. The hospital is staffed 
with a primary stroke coordinator who oversees all stroke alerts, and the ED staff responsible for 
carrying out this new workflow are the same employees currently practicing the old workflow. 
Education is the only additional resource required to implement this change in the ED. 
Study 
Measuring the outcomes of this implementation process will include a combination of 
personal observation, survey collection, chart audits, and metric data collection. Following the 
implementation, I will personally be walking around the ED making observations about how 
often the new workflow is being utilized, if there are any areas of this new workflow that are 
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impractical within the unit, and if there are any outward displays of frustration about the 
implementation from staff or patients. Once the implementation has been live for a short period 
of time, I will reach out to staff to fill out a survey regarding their satisfaction with the new 
workflow and allowing an area for them to anonymously make suggestions for areas of 
improvement within the new system. Once staff feedback have been collected, there will be a 
period of chart auditing by the primary stroke coordinator of patients with acute ischemic stroke 
who arrive via personal vehicle to ensure the standard order set has been not only utilized, but 
done so accurately and consistent across the documentation. These audit results will be reported 
back to myself by the primary stroke coordinator. Finally, the metric data of DNT will be 
collected from the patients who arrive to the ED during the implementation period and these 
numbers will hopefully trend down from where they previously were towards the goal of 43 
minutes.  
Act 
The findings will be utilized to go back and refine the improved workflow, primarily 
based on the staff feedback on practicality and the final metrics of whether or not this 
implementation does reduce DNT within the ED. If staff identify an area of the new workflow 
that is not able to be carried out in the manner that it was intended, or if there are any areas that 
they feel are continually being missed or overlooked, that will be the focus of change on a 
revised model. I anticipate that at least one revision will need to be made between 
implementation and final project completion in order for staff to utilize it consistently and value 
its worth towards reducing DNT.  
Chapter 4. FINDINGS AND OUTCOMES 
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Findings 
The planning of this project was a lengthy process that involved collaboration with more 
groups and stakeholders than we initially projected.  Developing a new workflow for patients 
arriving to the hospital via personal vehicle with an acute ischemic stroke was an improvement 
project that the primary stroke coordinator at the hospital had intended to complete for months 
prior to my arrival into the microsystem.  This worked to our advantage because the idea had 
already been suggested to management within the emergency department (ED) and to the 
physicians working within this unit, so it was not a new proposal, however none of us could have 
accounted for the interjection of the Covid-19 pandemic which complicated our ability to gain 
approvals.   
The initial step in the plan, do, study, act (PDSA) cycle was to assess the current 
workflow for not only stroke patients, but for the triage team in general, and design an improved 
workflow allowing the physician to assess stroke patients in the triage area to facilitate obtaining 
their CT scan prior to being placed in an ED room.  The new workflow was developed, but in 
further discussion with the hospital stroke committee it was suggested that we look into a nurse 
driven approach which would allow the triage nurse to initiate the stroke alert process and take 
the patient to CT.  Identifying exact roles for each team member involved proved to be a setback 
as the emergency department is an ever-changing environment in which staff availability and 
patient acuity can fluctuate from hour to hour.  The main areas of contention were ultimately 
deciding which staff members would be in charge of: 1) notifying the physician of the incoming 
stroke patient, 2) contacting the Patronus Neurology to initiate a tele-consult, and 3) physically 
taking the patient from the triage area to the CT scanner.  It was determined that flexibility will 
STROKE WORKFLOW ARRIVING BY PERSONAL VEHICLE  25 
 
   
 
be paramount in this workflow; staff knowing the steps of the new process in order will allow 
whichever staff is available to complete the next chain in the process.   
Ideally, the triage nurse will identify the symptoms of a stroke, determine last known well 
time (LKWT), call a level 1 stroke alert via a Mobile Heartbeat telephone device which will send 
a broadcast to patient registration, radiology, the physicians, and the charge nurse identifying that 
a stroke alert has been called.  This sets into motion the stroke alert process in which patient 
registration enters the patient into the electronic health system, radiology prepares a room to 
perform a head scan on the patient, the patient care technician contacts Patronus Neurology and 
obtains the mobile machine to place in the room, and the charge nurse aids in transporting the 
patient to radiology and then back to the pre-determined ED room. This workflow was compiled 
into a visual aide and presented to both the stroke committee and the ED physician’s group at 
their respective meetings which leads us into the “do” portion of the PDSA cycle in which the 
new workflow is approved.   
The new workflow for patients arriving to the ED via personal vehicle with stroke 
symptoms was approved by both groups, however at this point in the implementation process the 
Covid-19 pandemic had begun to consume the microsystem’s resources.  The influx of Covid-19 
patients meant that there were less available beds for patients to be treated, less available staff to 
bring into the implementation process, and less accessibility for myself as a student to access the 
unit.  Over the following weeks as cases continued to rise, the ED management enacted a change 
that all staff would be required to wear full personal protective equipment (PPE) garb to enter the 
unit and such precious resources were understandably not to be utilized by students.  We began 
to develop a plan to implement the project from outside the unit and brainstormed ways to 
provide education without being physically in the department, however the hospital eventually 
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restricted students from practicing within the facility at all.  Mental fatigue and staff burnout 
were also taken into consideration within this phase of the PDSA cycle, and with Covid-related 
policy changes occurring sometimes daily we ascertained that this was not the time to proceed 
with a major process change.   
The implementation of this project, however, was not abandoned.  Continuing on with the 
“do” phase of the PDSA cycle, we developed written and virtual education in the form of a 
pocket card for staff with the streamlined new workflow and a more in-depth power-point 
presentation explaining the reason for the change and the semantics of the workflow.  This 
education and all steps from this point will be set aside and held for future implementation after 
the Covid-19 pandemic subsides.   
A single walk-through of the new workflow was completed by the primary stroke 
coordinator with the unit educator on a patient who arrived via personal vehicle with stroke-like 
symptoms with LKWT less than 4.5 hours.  This continues the PDSA cycle into the “study” 
phase in which the original plan was to observe the new process, gain feedback from unit staff 
regarding the change, and record metrics of various times from door to intervention. As shown 
below in Figure 4, this change in workflow was extremely successful in reducing times from 
patient arrival to stroke alert broadcast, patient arrival to obtaining a head CT scan, and patient 
arrival to Patronus Neurology tele-consult as compared to the average times measured from the 
2020 fourth quarter utilizing the previous workflow. 
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Figure 4. Comparison Chart 
 Finally, in the “act” phase of the PDSA cycle it was intended that based on the metrics 
and staff feedback collected, the workflow would again be revised as necessary with new 
education developed and a new implementation date determined.  These steps of reviewing data 
collected, revising, re-educating, and re-implementing would continue on until the workflow was 
perfected to a point of proficiency where outcomes show marked improvement in time reduction 
and staff are confident in their ability to smoothly flow through the steps. Considering we were 
unable to complete this full cycle due to the Covid-19 pandemic, we would advise these to be the 
next steps in implementing this evidence-based practice project in the future. 
Evaluation 
The overall aim of this implementation project was to decrease the time from door to 
Alteplase (tPA) administration in applicable patients arriving to the ED via personal vehicle 
through the use of a revised workflow for staff from the one previously utilized. This 
overarching goal was to be met through the following objectives: 1) identify the areas of delay 
throughout the previous stroke process, 2) find solutions to overcome these delays to insert 
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logically into the workflow, 3) reorganize the workflow to prioritize obtaining the head CT 
before any other menial tasks, and 4) improve interdisciplinary communication throughout the 
department about stroke patient arrivals and treatment.   
To meet the first and second objective collectively, a fishbone diagram was developed 
and delays in the stroke workflow were categorized into six groups: patients, family, triage, 
physicians, process, and equipment.  Each of these hinderances were individually discussed and 
solutions to each were proposed and included in the revised workflow.  This alone was suspected 
to be enough to reduce the door to needle time, however we wanted to lessen this time span as 
much as possible which drove us to the next objective.  
Time management is a concept that nurses are taught early in school and work their 
whole career to master.  In order to attain the most efficient use of their time, nurses often group 
tasks together such as performing a physical assessment while dressing the patient in a hospital 
gown or establishing an intravenous line while drawing blood work. The largest delay in 
treatment was found to be placing the patient in the ED room prior to obtaining the head CT 
scan, and this was confirmed throughout the PDSA cycle in observing nurses clustering their 
tasks as described above.  Each small task that would seemingly only take a minute of the 
nurse’s time began to add up to a significant delay in the time from which the patient was placed 
in the ED room to the time they were taken out of that room for their CT scan.  Once this was 
identified, this objective was met through the use of a nurse-driven stroke alert protocol 
beginning in the triage department and ending in the ED room only after obtaining the head CT 
scan. 
Finally, we noted that interdisciplinary communication was going to be a large obstacle 
while early in the planning phase.  It appeared that blame was being passed around among the 
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different roles about who should be held accountable for each task in the previous workflow and 
this created animosity among the groups when these steps were being missed.  Clear role 
determination was going to be a significant factor in achieving this objective, which as discussed 
above is difficult in a department with fluctuating staff availability and patient acuity.  This 
objective was partially met as there are clear role definitions at every step except for one area.  
The exact staff member taking the patient from the triage desk to the CT scanner depends heavily 
on availability of the charge nurse, crowding in the ED on the triage nurse, and staffing ratios of 
patient care technicians.  The workflow was developed to allow any of these three personnel to 
complete this task with the understanding that it needs to be communicated to the rest of the 
team.  The use of the Mobile Heartbeat telephone device has played a useful role in achieving 
this objective as well because it allows the triage nurse to easily broadcast the stroke alert to all 
necessary team members from the touch of a button.        
Chapter 5. IMPLICATIONS AND CONCLUSION 
Project Impact on Quality Care and Cost 
While the primary stroke coordinator is a certified clinical nurse leader (CNL) and 
operates in many ways as such, this health system does not staff a CNL as a stand-alone role and 
therefore it seemed foreign to some within the microsystem. One of the primary functions of the 
clinical nurse leader is to utilize leadership skills and lateral integration to collaborate with the 
members of a microsystem to promote evidence-based practice changes to improve patient safety 
and outcomes. This project captured all aspects of this definition as we identified where there 
was a need for improvement, collaborated with interdisciplinary team members, and reviewed 
pertinent literature to reach a tangible workflow to implement to reduce door to needle time in 
ischemic stroke patients arriving via personal vehicle.  Through this project we were able to 
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improve the staff’s daily workflow while concurrently introducing the CNL role to members of 
this microsystem.       
This improvement project had been a discussion long before I stepped foot in the hospital 
as something that needed to be done do not only improve patient outcomes through a reduced 
door to needle time, but also to help cut hospital costs as a secondary objective. When patients 
come to the hospital with a medical emergency, they anticipate to receive the highest quality of 
care regardless of extenuating circumstances.  Developing a new workflow for stroke patients 
arriving via personal vehicle has helped the ED staff deliver on this promise by streamlining the 
necessary tasks in an order that allows for the least interruptions and by eliminating areas of 
common time delay.  Through patients receiving Alteplase in a timelier manner, they will 
appreciate a lower mortality rate and a lower incidence of lasting deficits, thus reducing their 
healthcare expenses and improving their all-around quality of life.  By receiving this higher 
quality of care, patients are more likely to return to this facility for their future medical needs, 
thus retaining the hospital’s overall fiscal stability.     
Significance 
The significance of this revised stroke workflow on nursing is that it will allow the ED 
nurses the best opportunities for successful Alteplase administration within the 4.5-hour window 
and within the national average of 60 minutes door to needle time. Medical professionals within 
the ED collectively want to treat each patient with the highest quality care to promote the best 
outcomes, but sometimes this is not feasible given staffing or policy constraints.  By eliminating 
interruptions and delays throughout the stroke alert process, nurses will be more confident in 
their ability to have stroke patients assessed and treated in a timely fashion.  This project has also 
empowered triage nurses to identify and call a stroke alert independently without relying on a 
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physician to confirm their suspicions or write orders in the electronic medical record.  This level 
of autonomy brings about a more open communication and a higher level of trust among a 
previously discorded relationship between physicians and nurses.       
Conclusion 
In conclusion, through the use of a revised workflow for patients arriving via personal 
vehicle with an ischemic stroke we were able to reduce the time from door to stroke alert called, 
CT scan obtained, and Patronus Neurology tele-consult placed on one patient. Areas of time 
delay were identified and remedied and a revised workflow was created and approved for use 
once the pandemic lessens.  An extensive literature review was performed to identify best 
practice interventions, and these were utilized to develop the revised workflow to improve 
patient outcomes. A nurse-driven protocol was initiated which empowers the triage nurse to 
identify a stroke, broadcast a level one stroke alert to necessary team members, and facilitate 
transport of the patient to the CT scanner all independent of physician guidance. Areas of 
breakdown in team communication were identified and resolved as well throughout this process.  
Due to the Covid-19 pandemic we were unable to fully implement the project at this time, 
however education and an implementation plan has been developed for future use. 
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to-needle time, (2) 
door-to-CT scan 
results, (3) door-to-
INR results, and (4) 
teleneurology 
consultation time 
“Stroke is a national health problem, 
affecting 7 million people in the 
United States and leading to 
795,000 hospitalizations” (Rhew et 
al., 2017, p. 33) 
 “Stroke is the leading cause of 
disability in the U.S.” (Rhew et al., 
2017, p. 33) 
 “Estimates indicate that every 40 
seconds someone sustains a stroke 
and every 4 minutes someone dies 
from a stroke” (Rhew et al., 2017, p. 
33) 
 “Stroke is the third leading cause of 
death with an estimated 750,000 
Americans experiencing a new or 
recurrent stroke event every year, 
contributing to 160,000 deaths 
annually” (Rhew et al., 2017, p. 33) 
“At least 50% of the population in 
the U.S. does not live within 60 
minutes travel time of a primary 
stroke center.” (Rhew et al., 2017, p. 
33) 
“Fewer than 5% of patients with an 
acute ischemic stroke who are 
eligible for acute treatment receive 
intravenous thrombolytic drugs” 
(Rhew et al., 2017, p. 33) 
 “During tPA administration, vital 
signs and neurologic checks should 
be completed and documented every 
15 minutes for 2 hours, then every 
30 minutes for 6 hours, then every 
hour until 24 hours after the tPA 
bolus is administered” (Rhew et al., 
2017, p. 37) 
This hospital reduced: (1) Door-to-
needle times from 111min to 76min, 
(2) door-to-CT results from 38min 
to 32.14min, (3) door-to-INR results 
from 51min to 46.6min, and (4) 
teleneurology request to video call 
from 15min to 13min (Rhew et al., 
2017, p. 39). 
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treatment for large vessel occlusion 
strokes” (Min-Yi et al., 2019, p. 2). 
 
“Because some patients with IHS 
may be ineligible for treatment with 
intravenous recombinant tissue 
plasminogen activator (rt-PA) due to 
comorbidities or contraindications, 
early recanalization through EVT 
becomes a vital therapeutic choice” 
(Min-Yi et al., 2019, p. 2). 
 
“The proportion of patients who 
received intravenous thrombolysis 
were significantly lower in the IHS 
group than in the COS group (3.6% 
vs 7.3%)” (Min-Yi et al., 2019, p. 
4).  
 
“Previous studies have suggested 
that patients with IHS had worse 
functional dependence, which was 
usually attributed to poor baseline 
function and delay in diagnosis and 
timely intervention” (Min-Yi et al., 
2019, p. 7). 
 
“A faster reperfusion time is usually 
associated with more favorable 
outcomes in acute ischemic stroke” 
(Min-Yi et al., 2019, p. 9). 
 
“Patients with IHS generally 
experience a substantial delay in 
stroke symptom recognition, 
neurological evaluation, and 
appropriate intervention” (Min-Yi et 
al., 2019, p. 9).  
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previous studies are 
referenced and cited, 
but there is no 
formal comparison 
or systematic review 
of the literature.  
 
Instruments: N/A 
“Neuroimaging is the most 
important biomarker to help 
differentiate between stroke 
subtypes and assess treatment 
eligibility” (Zerna et al., 2018, p. 
1247). 
 
“Therapeutic advances have led to 
intravenous thrombolysis with 
STROKE WORKFLOW ARRIVING BY PERSONAL VEHICLE  37 
 












Series paper will 





(Zerna at al., 
2018, p. 1247). 
 
Data Analysis: N/A 
tissue-type plasminogen activator 
and endovascular treatment for 
proximal vessel occlusion in the 
anterior cerebral circulation being 
standard care for acute ischemic 
stroke” (Zerna et al., 2018, p. 1247). 
 
“Ischemic stroke is caused by a 
focal occlusion or stenosis of an 
artery or multiple arteries in the 
brain or leading to the brain” (Zerna 
et al., 2018, p. 1247). 
 
“It [NIHSS score] is a guide that 
does not weight deficits or disability 
equally and is therefore a tool to aid, 
but not a substitute for, the clinical 
judgement of stroke severity” 
(Zerna et al., 2018, p. 1247). 
 
“Approximately 25% of all ischemic 
stroke is eligible for medical 
thrombolysis and 10-12% eligible 
for endovascular treatment” (Zerna 
et al., 2018, p. 1248). 
 
“Non-contrast CT allows 
differentiation between ischemic 
stroke and intracerebral hemorrhage 
and, in the case of an ischemic 
stroke, allows quantification of the 
extent of early ischemic changes by 
applying the Alberta Stroke 
Program Early CT Score 
(ASPECTS)” (Zerna et al., 2018, p. 
1248). 
 
“A normal non-contrast CT does not 
rule out an acute ischemic stroke” 
(Zerna et al., 2018, p. 1248). 
 
“Imaging is the most important 
biomarker in acute ischemic stroke; 
it can define the cause, show the 
extent of potentially salvageable 
brain tissue, and aid the selection of 
acute therapies” (Zerna et al., 2018, 
p. 1250). 
 
“Alteplase - a single chain 
recombinant tissue plasminogen 
activator (tPA) - has been 
successfully shown to be an 
efficacious treatment for stroke and 
subsequently marketed worldwide 
for acute ischemic stroke treatment” 
(Zerna et al., 2018, p. 1250). 
 
“[...] licensing of alteplase in a 3-
hour time window from stroke 
symptom onset” (Zerna et al., 2018, 
p. 1250). 
 
“There is a distinct benefit of 
alteplase that was greater the earlier 
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it was given, approaching a neutral 
effect at 270 min from symptom 
onset” (Zerna et al., 2018, p. 1250). 
 
“There is no average benefit of 
alteplase administration after 270 
min from stroke symptom onset” 
(Zerna et al., 2018, p. 1250). 
 
“The framework for acute ischemic 
stroke therapeutics is fast treatment 
with a door-to-needle time target of 
30 min or less and rapid escalation 
to endovascular treatment for 
patients with large vessel occlusion” 
(Zerna et al., 2018, p. 1254). 
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who presented to 
the adult ED and 
met criteria for 
stroke team 
activation between 
June 15, 2014 and 
June 15, 2015. 
 
Exclusion criteria 
included delays in 






















arriving by private 
vehicle to those 






model to assess the 
probability of 
meeting the national 













Based on the 
electronic 
timestamps for ED 
arrival and stroke 
team activation, 
door-to-activation 
(DTA) time for each 
patient in the stroke 
registry was 
calculated. 
“Intervention for stroke patients is 
time sensitive, with guidelines 
recommending administration of 
intravenous (IV) recombinant tissue 
plasminogen activator (rt-PA) 
within 4.5 hours of symptom onset” 
(Tennyson et al., 2019, p. 342). 
 
Of the 200 patients included, 83 
(41.5%) achieved DTA less than or 
equal to 15 minutes. 
 
DTA time ranged from less than 1 
minute to 3hr 37min. 
 
“Among patients who arrived via 
EMS without prehospital activation, 
32.1% achieved DTA less than or 
equal to 15min, compared to 52.1% 
among patients who did not arrive 
via EMS” (Tennyson et al., 2019, p. 
345). 
 
“Potential stroke patients arriving 
without EMS pre-notification were 
only 55% as likely to meet the 
national 15-minute goal for DTA 
time as those arriving via means 
other than EMS” (Tennyson et al., 
2019, p. 345). 
 
“Stroke patient’s arriving via the 
‘front door’ enjoyed more timely 
recognition and resource activation 
by ED staff than those arriving via 
the ambulance entrance if EMS had 
not already recognized the stroke 
symptoms in the field” (Tennyson et 
al., 2019, p. 346). 
 
“Observed results also may have 
been due to the success of EMS 
early identification and pre-
notification efforts [...] potentially 
creating a false sense of security and 
causing ED staff to become over-
reliant on EMS decision making” 
(Tennyson et al., 2019, p. 346). 
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Koga, M., von 
Kummer, R., 
Lansberg, M., 
Lindley, R. I., 
Murray, G., 
Olivot, J. M., . 


























assess the role or 
relationship 
among treatment 
delay, age, and 
stroke severity 
with good stroke 
outcomes at 3-6 
months as 















I Sample: 6756 
patients in nine 
randomized trials. 




and 3365 were 
given either placebo 
or control. 
 










randomized phase 3 
trials of intravenous 
alteplase for 
treatment of actue 
ischemic stroke for 






data from 9 
randomized trials. 
Retrospective checks 
confirmed that no 








assessment tool for 







National Institutes of 





was used, stratified 
by trial, to model the 
common linear 
dependence of the 
log odds of a 
particular outcome 
on allocation to 
alteplase, treatment 
delay, age, baseline 
stroke severity, and 
interactions between 
allocation to 
alteplase and each of 
these other baseline 
covariates” 
(Emberson et al., 
2014, p. 1931). 
 
Further analysis was 
completed with SAS 
version 9.3 and R-
version 2.11.1. 
“In the USA, the Food and Drug 
Administration has approved the use 
of alteplase only within 3h of stroke 
onset” (Emberson et al., 2014, p. 
1930). 
 
“Strong relationships existed 
between patient age, treatment 
delay, and stroke severity in all 
trials” (Emberson et al., 2014, p. 
1932). 
 
“Alteplase significantly increased 
the odds of a good outcome, with 
earlier treatment resulting in 
significantly greater proportional 
benefit” (Emberson et al., 2014, pp. 
1932-3).  
 
“We estimated the time at which 
alteplase has no effect to be 6.3h” 
(Emberson et al., 2014, p. 1933). 
 
“Age did not change the effect of 
alteplase on odds of a good outcome 
[...] nor did we find clear evidence 
that stroke severity modified the 
effect of alteplase.” (Emberson et 
al., 2014, p. 1933). 
 
“The proportional increase in risk of 
fatal intracranial hemorrhage was 
much the same, irrespective of 
treatment delay, age, or stroke 
severity” (Emberson et al., 2014, p. 
1933). 
 
“We provide clear evidence for 
improved odds of a good stroke 
outcome when treatment is started 
within 4.5h of ischemic stroke, with 
earlier treatment resulting in bigger 
proportional and absolute benefits” 
(Emberson et al., 2014, p. 1933). 
 










34(4), 76-82.  
Case Series Study 
 
Purpose: “The 
aim of this article 
is to describe 





from a stroke and 
to provide nurses 
with practical 







Methods: Case study 
approach to improve 
nurses’ 
understanding of 





were referenced and 
cited, but there was 
no formal literature 
review. 
“A stroke mimic is defined as a non-
vascular disease that presents with 
stroke-like symptoms, often 
indistinguishable from an actual 
stroke” (Catangui, 2019, p. 76). 
 
“The most common types of stroke 
mimic are seizures, syncope, sepsis, 
functional disorders such as 
conversion disorder, primary 
headache disorders such as 
migraine, brain tumor and metabolic 
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and stroke mimics 
















Data Analysis: Case 
study review and 
discussion 
disorders such as hypoglycemia” 
(Catangui, 2019, p. 76). 
 
“A patient experiencing a stroke 
mimic may present with symptoms 
that are similar to those of stroke, 
such as facial weakness, unilateral 
limb weakness, and visual and 
speech disturbances” (Catangui, 
2019, p. 77). 
 
“The onset of symptoms of stroke 
mimics usually occur progressively, 
whereas the onset of a stroke is 
usually acute” (Catangui, 2019, p. 
80). 
7 Campbell, B. 






Levi, C. R., 
Hsu, C., 







M., Barber, P. 
A., Butcher, 
K. S., De 
Silva, D.,A., 
Bladin, C. F., 






















Purpose: “We did 
a meta-analysis of 
individual patient 











4.5-9h after onset 
or wake-up stroke 
who were imaged 
with CT perfusion 
or perfusion-
diffusion MRI” 
(Campbell et al., 
2019, p. 140). 
I Sample: 414 
patients were 
included from 3 
trials. 
 
213 patients were 
assigned to receive 
















January 1, 2006 and 
March 1, 2019 of 







placebo in adults 
with hemispheric 
ischemic stroke 
more than 4.5h after 
stroke onset or 
wake-up stroke who 
had pretreatment 
imaging with CT 
perfusion or 
perfusion-diffusion 
MRI were eligible 
for inclusion. 
Methods: Completed 
a systematic search 






‘alteplase,’ or ‘tPA.’  
 
The reference list of 
a previous 
systematic review of 
thrombolysis was 
reviewed for 





was searched for 
international studies 
of ischemic stroke 














improvement at 3 
months, functional 
independence at 3 









“Patients with ischemic stroke 4.5-
9h from stroke onset or wake-up 
stroke with salvageable brain tissue 
who were treated with alteplase 
achieved better functional outcomes 
than did patients given placebo” 
(Campbell et al., 2019, p. 139). 
 
“76 (36%) of 211 patients in the 
alteplase group achieved the 
primary outcome of excellent 
functional outcome at 3 months 
compared with 58 (29%) of 199 
patients in the placebo group” 
(Campbell et al., 2019, p. 143). 
 
“The number of patients with 
symptomatic intracerebral 
hemorrhage was significantly higher 
in the alteplase group than the 
placebo group [...] however, no 
significant differences were 
identified in mortality between the 
alteplase and placebo groups.” 
(Campbell et al., 2019, p. 143). 
 
“[there is] strong evidence in 
support of thrombolysis for patients 
with favorable perfusion imaging 
4.5-9h after stroke, including 
patients with wake-up stroke” 
(Campbell et al., 2019, p. 146). 
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36h of treatment, 
neurological 
deterioration of 4 or 




National Institutes of 










were used and 
analyzed. 
 

































































stroke” (Man et 
al., 2020, p. 
2171). 
IV Sample: 61,426 
Medicare 
beneficiary patients 
aged 65yr or older 
who were treated 
for acute ischemic 
stroke with IV-tPA 
within 4.5hr from 
the time of last 
known well. 
 
Setting: Get With 
the Guidelines – 
Stroke participating 
hospitals between 
January 1, 2006 and 
December 31, 2016.  
 
Most patients were 
treated at teaching 
hospitals (77.7%) 
and primary stroke 
centers (73.2%); 3% 






required to (1) be 
65yrs or older, (2) 
have a discharge 
diagnosis of acute 
ischemic stroke, (3) 
have been treated 
with IV-tPA within 
4.5hr of the LKWT, 




were instructed to 
collect the data from 
the Get With The 







records were linked 
to Medicare claims 







readmission, and the 
composite of all-
cause mortality or 
readmission at 1 
year.  
 
A secondar outcome 
was 1-year 
cardiovascular 









“Shorter door-to-needle times were 
associated with lower all-cause 
mortality and lower all-cause 
readmission at 1 year” (Man et al., 
2020, p. 2170). 
 
“Intravenous tissue plasminogen 
activator (tPA) has been 
demonstrated in randomized trials to 
improve 3-month functional 
outcomes after acute ischemic 
stroke, and 1-year to 1.5-year 
functional outcomes” (Man et al., 
2020, p. 2171). 
 
“A series of key best practice 
strategies were disseminated to 
hospitals with the goal to achieve 
door-to-needle times within 60 
minutes for at least 50% of patients 
treated with tPA” (Man et al., 2020, 
p. 2171). 
 
“More patients that arrived during 
off hours were treated within longer 
door-to-needle times” (Man et al., 
2020, p. 2173). 
 
“Patients who received tPA after 45 
minutes of hospital arrival had 
worse long-term outcomes than 
those treated within 45 minutes of 
hospital arrival, including 
significantly higher all-cause 
mortality” (Man et al., 2020, p. 
2173). 
 
“Patients who received tPA after 60 
minutes of hospital arrival vs within 
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to-needle time, (5) 
not have been 
treated with a 
concomitant 
therapy, (6) have 
had the admission 
be the first for 
stroke during the 
study period, and 
(7) not have been 
transferred to 





because they could 




Person x2 test was 
used for categorical 
variables and the 
Wilcoxon rank-sum 







between 2 groups. 
 
Cox proportional 
hazards models were 












were generated to 
estimate the 
incidence of each 





SAS version 9.4. 
60 minutes of hospital arrival had 
significantly higher adjusted all-
cause mortality, higher all-cause 
readmission, higher all-cause 
mortality or readmission, and higher 
cardiovascular readmission” (Man 
et al., 2020, p. 2179). 
 
“Every 15-minute increase in door-
to-needle times was significantly 
associated with higher all-cause 
mortality, [...] higher all-cause 
readmission, and higher all-cause 
mortality or readmission “Man et 
al., 2020, p. 2179). 
 
“Every 15-minute increase in door-
to-needle time up to 90 minutes was 
significantly associated with worse 
1-year outcomes” (Man et al., 2020, 
p. 2179). 
 
“A door-to-needle time within 30 
minutes was not associated with 
even better outcomes [than within 
45 minutes]” (Man et al., 2020, p. 
2182). 
9 Jaffe, T. A., 
Goldstein, J. 
































crowding and the 
delivery of timely 
emergency stroke 
care” (Jaffe et al., 










IV Sample: 1379 
patients with 
ischemic stroke 
presented during the 
study period of July 
2016 – August 
2018.  
 
Of the 1379 total 
sample patients, 495 
patients were 
potentially eligible 
for intervention and 
after exclusion 
criteria a remaining 











Included all patients 
over 18yrs of age 
Methods: 
Prospectively 
collected data from 





logs to determine the 
degree of ED 
crowding at the time 
of patients’ 
presentation and 




were used to 
examine the 
relationship between 





National Institutes of 
Health Stroke Scale 
(NIHSS) 
“We found no significant delays in 
stroke care delivery associated with 
increased ED crowding” (Jaffe et 
al., 2020, p. 892). 
 
“National guidelines recommend 
administration of alteplase within 60 
minutes of patient presentation” 
(Jaffe et al., 2020, p. 892). 
 
Previous studies have reported that 
“increased crowding was associated 
with poorer performance on door-to-
imaging times (DIT)” (Jaffe et al., 
2020, p. 893). 
 
“Increased crowding activations 
occurred Monday-Thursday, with 
the median time of activation 
1:35pm” (Jaffe et al., 2020, p. 894). 
 
“Median DIT among this cohort was 
26 minutes and did not significantly 
differ by ED capacity constraints at 
time of presentation” (Jaffe et al., 
2020, p. 895). 
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patients to eliminate 
anyone who may 




analysis included all 
patients arriving 
within 4.5hr of last 






analysis included all 
patients arriving 
within 8hr of 
LKWT with NIHSS 






tests, chi-square, and 
Wilcoxon rank-sum 





using the Stata 14.2 
program. 
“Among the 82 alteplase-treated 
patients in our sample, median DTN 
was 43 minutes and did not 
significantly vary by ED capacity 
status at time of presentation” (Jaffe 
et al., 2020, p. 895). 
 
“Among the 52 patients who 
received endovascular therapy, 
median DTP was 68.5 minutes and 
did not vary by ED capacity status 
at time of presentation” (Jaffe et al., 
2020, p. 895). 
 
“One potential explanation for our 
findings could be that times of peak 
crowding occurred concurrently 
with times of increased resource 
availability” (Jaffe et al., 2020, p. 
897). 
10 Yang, J. M., 
Park, Y. S., 
Chung, S. P., 
Chung, H. S., 
Lee, H. S., 
You, J. S., 




n of a clinical 
pathway 

























purpose of this 








in the time 




regardless of the 
time from arrival 
in the ED, by 
eliminating off-
hour and weekend 
effects in 
ischemic stroke” 
(Yang et al., 
2014, p. 885). 
III Sample: 649 
consecutive patients 
were admitted to the 
ED and met 
inclusion during the 
study period of 






with an annual ED 





The study included 
all patients within 
the study period 
with ischemic 
stroke or transient 
ischemic attack who 
presented to the ED 
within 12 hours of 
onset of symptoms. 
Patients were 
excluded from the 
study if a 
hemorrhagic stroke 
or brain tumor was 
revealed by 
noncontrast CT or if 
another medical 
Methods:  








system was utilized 
which, when 
activated, includes 
the entering of 
predetermined 
standing order sets 
and provides 
specific protocols 




classified into one of 
four groups based on 
their time of arrival 
in the ED. and the 
BEST program and 
thus CPOE were 
activated by the 
medical personnel in 






“Admission on weekends and off-
hours has been associated with poor 
outcomes and mortality from acute 
stroke” (Yang et al., 2014, p. 884). 
 
“No time intervals differed 
significantly among the 4 patient 
groups who received intravenous 
administration of tissue 
plasminogen activator (IV-tPA)” 
(Yang et al., 2014, p. 884). 
 
“Use of IV-tPA was not affected by 
arrival in the ED on off-days or 
weekends” (Yang et al., 2014, p. 
884). 
 
“Intra-arterial thrombolysis or 
intravenous administration of tissue 
plasminogen activator (IV-tPA) can 
improve clinical outcomes for many 
patients with ischemic stroke if 
conducted rapidly after the onset of 
acute stroke” (Yang et al., 2014, p. 
884). 
 
Previous studies suggested that 
“admission on the weekend or 
during off-hours has also been 
associated with poor outcomes and 
mortality from acute stroke” (Yang 
et al., 2014, p. 884). 
 
“Implementation of a clinical 
pathway (CP) significantly reduced 
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according to 30 days 
in-hospital mortality, 
in-hospital mortality, 
and the modified 
Rankin score during 




National Institute of 















Post hoc analysis 
was performed by 








The log-rank test 
was performed for 
comparisons among 
4 groups. 
the time interval from patient arrival 
in the ED to evaluation and delivery 
of thrombolytic treatment. In 
addition, it led to an increase in the 
number of patients treated with 
thrombolytic agents” (Yang et al., 
2014, p. 885). 
 
“The rates of treatment with IV-tPA 
were not affected by off-day and 
weekend hours” (Yang et al., 2014, 
p. 886). 
 
“A systematic and well-organized 
alert system could sufficiently 
attenuate disparities in time intervals 
irrespective of arrival time in the 
ED” (Yang et al., 2014, p. 887). 
 
“Off-hour and weekend effects 
might be influenced by many 
factors, including discontinuity of 
care, inadequate staffing, reduced 
availability of interventions, and an 
overall reduction in supervision of 
patients during off-hours and 
weekends” (Yang et al., 2014, p. 
887). 



































(DTN) as a result 
of implementing 




III Sample: 34 patients 
received tPA and 
had door-to-CT, 
door-to-CT result, 
and DTN times 
monitored. 
 
Setting: Part of a 
multistate health 
care system located 
in a large 
metropolitan area. 
 
The facility treats 
1,000 to 1,200 TIA 
and stroke patients 
per year and 






Patients eligible to 
receive tPA 
between the study 
Methods: Performed 
a literature review 
compared to their 
current processes to 








tasks such as 
monitor attachment, 
second IV line, and 
assessment 
simultaneously 
during the period in 
between the CT scan 






“Since the introduction of 
intravenous (IV) recombinant tissue 
plasminogen activator (tPA) as a 
treatment for ischemic stroke 
patients, stroke has declined from 
the third to the fourth leading cause 
of death in the United States” 
(Speirs & Mitchell, 2015, p. 381). 
 
“For each minute during which a 
large-vessel ischemic stroke is 
untreated, 1.9 billion neurons and 
13.8 billion synapses are lost. For 
each hour the stroke is untreated, the 
same neuronal loss develops that 
would occur in 3.6 years of normal 
aging” (Speirs & Mitchell, 2015, p. 
381). 
 
“Current recommendations are to 
administer IV tPA within 60 
minutes of arrival to the emergency 
department” (Speirs & Mitchell, 
2015, p. 381). 
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period of June 2013 
through June 2014. 
Data Analysis: 
Specific modes of 
analysis not 
discussed, only 
stated time reduction 
results. 
“For every 15-minute reduction in 
door-to-needle (DTN) time, the risk-
adjusted in-hospital mortality rate 
decreases by 5%” (Speirs & 
Mitchell, 2015, p. 381). 
 
“No pre-notification of the 
impending arrival of a stroke 
patient, a protracted triage process, 
location of the CT scanner outside 
the emergency department, lack of a 
dedicated stroke team process, and 
standardized stroke treatment 
protocols are hurdles to timely 
stroke identification and tPA 
administration” (Speirs & Mitchell, 
2015, p. 381). 
 
“Most time is lost in the prehospital 
setting primarily because patients 
delay seeking medical attention” 
(Speirs & Mitchell, 2015, p. 382). 
 
“Creating and training stroke teams, 
implementing preapproved 
standardized treatment protocols, 
obtaining administrative support, 
and monitoring performance are 
associated with early tPA use” 
(Speirs & Mitchell, 2015, p. 382). 
 
“3 barriers associated with delayed 
tPA administration: (1) inefficient 
patient flow, (2) serial processing of 
multiple tasks, and (3) delayed 
laboratory results for patients taking 
anticoagulants” (Speirs & Mitchell, 
2015, p. 382). 
 
“After streamlining the approach by 
taking the patient directly to the CT 
suit on arrival, performing required 
tasks simultaneously, and adopting 
POC testing for patients who have 
undergone anticoagulation, the 
average DTN time decreased from 
60 to 39 minutes and the percentage 
of patients receiving tPA increased 
from 52% to 78%” (Speirs & 
Mitchell, 2015, p. 382). 
 
“A ‘stroke box’ fully stocked with 
all necessary supplies for tPA 
administration is available in the 
emergency department” (Speirs & 
Mitchell, 2015, p. 383). 
 
“Postponing nonessential 
components of care until after 
completion of the CT scan does not 
appear to result in any harm to the 
patient or interfere with routine CT 
operations” (Speirs & Mitchell, 
2015, p. 385). 
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12 Kamal, N., 
Jeerakathil, 
T., Stang, J., 
Liu, M., 
Rogers, E., 
Smith, E. E., 





















looks at the effect 
on patient 








patients across an 
entire population” 
(Kamal et al, 
2020, p. 2340). 
IV Sample: 2048 
patients received 
thrombolysis in the 
pre-period from 
July 1, 2007 to 
March 31, 2015, 
and 689 patients in 
the post-period 
from October 1, 
2016 to December 
31, 2017.  
 
Setting: Conducted 
over 10 years in the 
Canadian province 









alteplase in the 
Canadian province 







from April 1, 2015 









Patients who were 
not residing in 
Alberta at the time 









used to lower DNTs 
across Alberta. This 
consisted of the 
recruitment of 
interdisciplinary 
teams from all the 
stroke centers, 3 
face-to-face 
workshops, site 
visits to all stroke 
centers, 10 webinars, 
data audit, data 







and the Alberta 
Provincial Stroke 
Strategy were used 
to collect data. 
 
National Institutes of 







Data Analysis: The 
x2 test was used for 




















A zero inflated 
negative binomial 
regression model 
was used for 
“The US Target Stroke initiative has 
set the target DNT to a median of 45 
minutes” (Kamal et al., 2020, p. 
2339). 
 
“The DNT dropped from a median 
of 70 minutes to 39 minutes for 
those patients who received 
alteplase within 4.5 hours of onset” 
(Kamal et al., 2020, p. 2341). 
 
“The adjusted percentage of patients 
discharged home from acute care 
increased from 46.5% to 59.5%, [...] 
the adjusted in-hospital mortality 
decreased from 14.5% to 10.5%” 
(Kamal et al., 2020, pp. 2341-2). 
 
“The median 90-day home time 
increased from 39 days to 71 days” 
(Kamal et al., 2020, p. 2342). 
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13 Elder, K. G., 
Lemon, S. K., 






























of a study to 
determine the 
impact of 
physician use of a 
medication order 
set on compliance 
with national 
quality standards 
for acute stroke 
treatment are 
presented” (Elder 
et al., 2015, p. 
S6). 
II Sample: A total of 
120 patient charts 
were reviewed. 
 
70 patients from 
hospital A from 
January 1, 2007 to 
August 31, 2011. 
 
30 patients from 
hospital B and 20 
from hospital C 
both from 
September 1, 2009 











excluded if they 
were pregnant, less 
than 18yrs of 
greater than 89yrs 
of age, incarcerated, 
or had hemorrhagic 
stroke. 
Methods: A uniform 
medication order set 
was created by a 
multidisciplinary 
team of stroke 




was to determine if 
the use of a 
predifined order set 
resulted in 
adherence to all 
eight required 




objectives were to 
determine rates of 
adherence to specific 
standards, the impact 
of standard 
adherence on length 
of hospitalization, 






generator was used 
to select patients 




square and Fisher’s 
exact tests were used 




U test was used for 





Excel and SPSS, 
version 19.0. 
“Stroke is still the fourth leading 
cause of death nationwide” (Elder et 
al., 2015, p. S6).  
 
“Almost 90% of strokes are 
ischemic” (Elder et al., 2015, p. S6). 
 
“Current guidelines for ischemic 
stroke advocate the use of 
intravenous tissue plasminogen 
activator, the early use of 
antithrombotics, venous 
thromboembolism prophylaxis, 
anticoagulation in patients with 
atrial fibrillation, and lipid-lowering 
therapy” (Elder et al., 2015, p. S6). 
 
“Individual patients who were 
treated without physician use of the 
order set were more than twice as 
likely as those in the comparator 
group to receive care that was not in 
compliance with at least one of the 
eight mandatory quality standards” 
(Elder et al., 2015, p. S6). 
 
“There are eight mandatory 
standards, which require that the 
patient receive (1) VTE prophylaxis, 
(2) anticoagulation therapy for atrial 
fibrillation or flutter, (3) 
thrombolytic therapy, and (4) 
antithrombotic therapy by the end of 
hospital day 2; are discharged on (5) 
statin therapy and (6) anti-
thrombotic therapy; and receive (7) 
stroke education and (8) assessment 
for rehabilitation” (Elder et al., 
2015, p. S7). 
 
“Standing orders as a part of a 
multidisciplinary acute stroke 
treatment program have been shown 
to decrease length of stay and cost 
in stroke patients” (Elder et al., 
2015, p. S7). 
 
“The Brain Attack Coalition 
recommends using written care 
protocols when treating patients 
with stroke and including the 
protocols within an electronic 
medical record (EMR) when 
feasible” (Elder et al., 2015, p. S7). 
 
“Of those physicians who used the 
order set, 94% were neurologists” 
(Elder et al., 2015, p. S8). 
 
“A patient treated without the order 
set was 2.4 times more likely to 
receive care that was not in 
compliance with all eight mandatory 
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standards” (Elder et al., 2015, p. 
S8). 
 
“The updated recommendations for 
primary stroke centers suggest 
efforts to incorporate order sets into 
the EMR whenever possible” (Elder 
et al., 2015, p. S9). 
 
14 Tran, D., Zhu, 
Z., Shafie, M., 
Abcede, H., 
Stradling, D., 






















effect of a simple 
quality 
improvement 
initiative on DNT 
for IVT” (Tran et 
al., 2019, p. 1). 
III Sample: 90 patients 
in the pre-
intervention group 
from January 2018 
to December 2014 
and 136 patients in 
the post-
intervention group 
from January 2016 
to December 2017. 
 
Setting: University 
of California Irvine 
Certified Stroke 
Center between 
















included three parts 
and allowed the 
stroke team to (1) 
manage 
hypertension in the 
emergency room, (2) 
make the decision 
for IVT before 
getting blood test 
results unless the 
patient was taking 
oral anticoagulants, 
and (3) give IVT in 
the CT suite. 
 
Instruments: 
National Institutes of 






Data Analysis: t-test 
or Wilcoxon rank-
sum test were used 
for continuous 






was used to compare 




SPSS software – 
IBM Version 23. 
“Intravenous thrombolysis (IVT) 
with tissue-type plasminogen 
activator (tPA) is the proven 
medical therapy for acute ischemic 
stroke (AIS), with faster 
administration resulting in better 
outcomes” (Tran et al., 2019, p. 1). 
 
“Acute ischemic stroke is 
characterized by the sudden loss of 
blood circulation to an area of the 
brain, resulting in a corresponding 
loss of neurologic function” (Tran et 
al., 2019, p. 2). 
 
“The median DNT was reduced by 
23min from 63 minutes in the pre-
intervention group to 40 minutes in 
the post-intervention group” (Tran 
et al., 2019, p. 3). 
 
“Significantly more patients in the 
post-intervention group received 
IVT within 60min (81.6% vs. 
46.7%) and 45min (64.0% vs. 
17.8%) than in the pre-intervention 
group” (Tran et al., 2019, p. 3). 
 
“Uncontrolled hypertension is one 
of the most frequently reported 
factors causing delayed DNT [...] 
[and] was associated with more than 
30min delay in DNT” (Tran et al., 
2019, p. 3). 
 
“Waiting for blood testing results is 
another common reason for delay up 
to 60min in some eligible patients” 
(Tran et al., 2019, p. 4). 
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whether the time 
from arrival at ED 
to various care 
steps differed 
between patients 
with minor and 
non-minor stroke 
IV Sample: 356 
patients received IV 
tPA treatment 
during the study 




91 patients were 
classified in the 
minor stroke group 
and 265 patients 
Methods: This study 
was performed 
retrospectively using 









“The rapid administration of IV tPA 
is crucial for improving the 
outcomes of acute stroke treatment” 
(Yoo et al., 2018, p. 53). 
 
“The initial diagnosis at triage, and 
the behavior and actions of the 
hospital personnel who are involved 
in acute stroke care in the ED may 
differ according to the stroke 
severity” (Yoo et al., 2018, p. 53). 
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activator (IV tPA) 
during a 1.5 year 
period in 5 
hospitals. (Yoo et 
al., 2018, p. 52). 












received IV tPA 
during a 1.5 year 
period in 5 hospitals 
were included. 
time, notification-to-





National Institutes of 






Get With The 
Guidelines – STroke 
program database. 
 
Data Analysis: Time 
intervals were 
compared using chi-











performed using R 
version 3.4.1. 
“The door-to-needle time was 
significantly longer in the minor 
stroke group than it was in the non-
minor stroke group (43min vs. 
37min)” (Yoo et al., 2018, p. 54). 
 
“Door-to-notification time (7min vs. 
5min) and door-to-imaging time 
(20min vs. 16min) were 
significantly longer in the minor 
stroke group than they were in the 
non-minor stroke group” (Yoo et al., 
2018, p. 54). 
 
“The initial procedures performed in 
the ED might be delayed in stroke 
patients with mild neurologic 
deficits” (Yoo et al., 2018, p. 55). 
 
“The rapid diagnosis of stroke may 
be occasionally difficult in patients 
with isolated symptoms or minor 
neurologic deficits. This may occur 
more frequently in the ED where 
nurses and ED physicians are 
engaged in the initial steps of triage” 
(Yoo et al., 2018, p. 57). 
 
“Misdiagnosis at the initial 
presentation to the ED might cause 
delays in the subsequent steps” 
(Yoo et al., 2018, p. 57). 
 
“The actions of hospital staff in the 
ED may be influence by the 
conditions of the patients and the 
status of the ED [...] it is likely that 
ED personnel respond more rapidly 
to patients with severe stroke than 
they do those with minor stroke” 
(Yoo et al., 2018, p. 57). 
 
“Educational programs aimed at the 
ED staff should inform them on how 
to recognize stroke symptoms and 
emphasize the need for rapid 
treatment in patients with minor 
stroke” (Yoo et al., 2018, p. 57). 
 
  
